Compounds > escitalopram
Page last updated: 2024-08-23

escitalopram and 2019 Novel Coronavirus Disease

escitalopram has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Asanova, AE; Assonov, DO; Khaustova, OO; Omelyanovich, VY1
Khosravi, M1

Reviews

1 review(s) available for escitalopram and 2019 Novel Coronavirus Disease

ArticleYear
Candidate Psychotropics against SARS - CoV - 2: A Narrative Review.
    Pharmacopsychiatry, 2022, Volume: 55, Issue:1

    Topics: COVID-19; Escitalopram; Fluoxetine; Humans; Psychotropic Drugs; SARS-CoV-2

2022

Other Studies

1 other study(ies) available for escitalopram and 2019 Novel Coronavirus Disease

ArticleYear
THERAPY OF POST-COVID DEPRESSION: A PROACTIVE PSYCHOSOMATIC APPROACH.
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2023, Volume: 51, Issue:1

    Topics: COVID-19; Depression; Escitalopram; Humans; Quality of Life; Treatment Outcome

2023